Memantine (namenda) for neuropathic pain

American Journal of Hospice and Palliative Medicine

Volumn 26, Issue 1, 2009, Pages 57-59

  Rogers, Mailien ^a,b   Rasheed, Atif ^a   Moradimehr, Abdolali ^b   Baumrucker, Steven J ^a,c,d  

^a East Tennessee State University   (United States)

^b University of Appalachia   (United States)

^c USA   (United States)

^d NONE   (United States)

Author keywords

Memantine; Namenda; Neuropathic pain; NMDA antagonist

Indexed keywords

EID: 59549106250     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909108330025     Document Type: Article

References (26)

1. Wallace MS Diagnosis and treatment of neuropathic pain. Curr Opin Anaesthesiol. 2005 ; 18: 548-554.
2. Nikolajsen L., Gottrup H., Kristensen A., Jensen T. Memantine (an N-methyl-D-aspartate receptor antagonist) in the treatment of neuropathic pain after amputation or surgery: a randomized, double-blinded, cross-over study. Anesth Analog. 2000 ; 91: 960-966.
3. In: Taylor RB, David AK, Johnson TA, Phillips DM, Scherger JE, eds. Family Medicine: Principles and Practice. 5 th ed. New York, NY: Springer Publishing Co ; 1998.
4. Fauci AS, Braunwald E., Kasper DL, et al. Harrison's Principles of Internal Medicine. 1 7 th ed. New York, NY: McGraw-Hill Professional ; 2008.
5. Sang CN, Booher S., Gilron I., Parada S., Max MB Dextromethorphan and memantine in painful diabetic neuropthy and postherpatic neuralgia. Anestheology. 2002 ; 96: 1053-1061.
6. Forst T., Smith T., Schutte K., Marcus P., Pfützner A. ; CNS 5161 Study Group. Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain. Br J Clin Pharmacol. 2007 ; 64: 75-82.
7. Bennett GJ Update on the neurophysiology of pain transmission and modulation: focus on the NMDAreceptor. J Pain Symptom Manage. 2000 ; 19: S2 - S6.
8. Galer BS Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology. 1995 ; 45: S17 - S25.
9. Schifitto G., Yiannoutsos CT, Simpson DM, et al. A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. J Neurovirol. 2006 ; 12: 328-331.
10. Gilron I., Watson CP, Cahill CM, Moulin DE Neuropathic pain: a practical guide for the clinician. CMAJ. 2006 ; 175: 265-275.
11. Burton C., Maurer DD Pain suppression by transcutaneous electrical nerve stimulation. IEEE Trans Biomed Eng. 1974 ; 21: 81-88.
12. Galer BS Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology. 1995 ; 45: S17 - S25.
13. Abuaisha BB, Costanzi JB, Boulton AJ Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study. Diabetes Res Clin Pract. 1998 ; 39: 115-121.
14. McQuay H., Carroll D., Jadad AR, Wiffen P., Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ. 1995 ; 311: 1047-1052.
15. Kingery WS A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain. 1997 ; 73: 123-139.
16. McQuay HJ, Tramer M., Nye BA, Carroll D., Wiffen PJ, Moore RA A systematic review of antidepressants in neuropathic pain. Pain. 1996 ; 68: 217-227.
17. Watson CP, Vernich L., Chipman M., Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology. 1998 ; 51: 1166-1171.
18. Max MB, Kishore-Kumar R., Schafer AC, et al. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain. 1991 ; 45: 3-9.
19. Max MB, Lynch SA, Muir J., Shoaf SE, Smoller B., Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 1992 ; 326: 1250-1256.
20. Cohen KL, Harris S. Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Arch Intern Med. 1987 ; 147: 1442-1444.
21. Moosa RS, McFadyen ML, Rubin J. Carbamazepine and its metabolites in neuralgias: concentration-effect relations. Eur J Clin Pharmacol. 1993 ; 45: 297-301.
22. Bleakman D., Alt A., Nisenbaum ES Glutamate receptors and pain. Semin Cell Dev Biol. 2006 ; 17: 592-604.
23. Lipton SA Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation. Curr Drug Targets. 2007 ; 8: 621-632.
24. Sinis N., Birbaumer N., Gustin S., et al. Memantine treatment of complex regional pain syndrome, preliminary report of six cases. Clin J Pain. 2007 ; 23: 237-240.
25. Wiech K., Kiefer RT, Topfner S., et al. Placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain. Anesth Analg. 2004 ; 98: 408-413.
26. Schifitto G., Yiannoutsos CT, Simpson DM, et al. A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. J Neurovirol. 2006 ; 12: 328-331.